Annual ROE
-169.75%
-53.19%-45.63%
December 31, 2022
Summary
- As of February 10, 2025, FRLN annual return on equity is -169.75%, with the most recent change of -53.19% (-45.63%) on December 31, 2022.
- During the last 3 years, FRLN annual ROE has fallen by -106.29% (-167.49%).
Performance
FRLN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-110.68%
-14.36%-14.91%
September 1, 2023
Summary
- As of February 10, 2025, FRLN quarterly return on equity is -110.68%, with the most recent change of -14.36% (-14.91%) on September 1, 2023.
- Over the past year, FRLN quarterly ROE has dropped by -9.30% (-9.17%).
Performance
FRLN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FRLN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.6% | -9.2% |
| 3 y3 years | -167.5% | -93.8% |
| 5 y5 years | -17.2% | - |
FRLN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +45.6% | at low | +33.7% | at low |
| 5 y | 5-year | +340.2% | at low | +463.0% | at low |
| alltime | all time | +340.2% | at low | +463.0% | at low |
Freeline Therapeutics Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -110.68%(+14.9%) |
| Jun 2023 | - | -96.32%(+5.1%) |
| Mar 2023 | - | -91.63%(-15.2%) |
| Dec 2022 | -169.75%(+45.6%) | -108.11%(+6.6%) |
| Sep 2022 | - | -101.38%(+4.6%) |
| Jun 2022 | - | -96.92%(+5.9%) |
| Mar 2022 | - | -91.56%(+10.6%) |
| Dec 2021 | -116.56% | - |
| Dec 2021 | - | -82.79%(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -71.20%(+12.7%) |
| Jun 2021 | - | -63.16%(+8.1%) |
| Mar 2021 | - | -58.43%(+11.8%) |
| Dec 2020 | -38.56%(-39.2%) | - |
| Dec 2020 | - | -52.24%(-8.5%) |
| Sep 2020 | - | -57.12%(+75.1%) |
| Jun 2020 | - | -32.62%(+65.9%) |
| Mar 2020 | - | -19.66% |
| Dec 2019 | -63.46%(-56.2%) | - |
| Dec 2018 | -144.89% | - |
FAQ
- What is Freeline Therapeutics Holdings annual return on equity?
- What is the all time high annual ROE for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings annual ROE year-on-year change?
- What is Freeline Therapeutics Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings quarterly ROE year-on-year change?
What is Freeline Therapeutics Holdings annual return on equity?
The current annual ROE of FRLN is -169.75%
What is the all time high annual ROE for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high annual return on equity is -38.56%
What is Freeline Therapeutics Holdings annual ROE year-on-year change?
Over the past year, FRLN annual return on equity has changed by -53.19% (-45.63%)
What is Freeline Therapeutics Holdings quarterly return on equity?
The current quarterly ROE of FRLN is -110.68%
What is the all time high quarterly ROE for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high quarterly return on equity is -19.66%
What is Freeline Therapeutics Holdings quarterly ROE year-on-year change?
Over the past year, FRLN quarterly return on equity has changed by -9.30% (-9.17%)